Effect of the type of surgical indication on mortality in patients with infective endocarditis who are rejected for surgical intervention by Ramos Martínez, Antonio et al.
Accepted Manuscript
Effect of the type of surgical indication on mortality in patients
with infective endocarditis who are rejected for surgical
intervention
Antonio Ramos-Martínez, Jorge Calderón-Parra, José Mª. Miró
Meda, Patricia Muñoz García, Hugo Rodríguez Abella, Maricela
Valerio Minero, Arístides de Alarcón González, Rafael Luque
Márquez, Juan Ambrosioni, Mª. Carmen Fariñas Álvarez, Miguel
Ángel Goenaga Sánchez, José Antonio Oteo Revuelta, Francisco
Javier Martínez Marcos, David Vinuesa García, Fernando
Domínguez, Spanish Collaboration on Endocarditis — Grupo de





To appear in: International Journal of Cardiology
Received date: 25 June 2018
Revised date: 18 December 2018
Accepted date: 2 January 2019
Please cite this article as: Antonio Ramos-Martínez, Jorge Calderón-Parra, José Mª. Miró
Meda, Patricia Muñoz García, Hugo Rodríguez Abella, Maricela Valerio Minero, Arístides
de Alarcón González, Rafael Luque Márquez, Juan Ambrosioni, Mª. Carmen Fariñas
Álvarez, Miguel Ángel Goenaga Sánchez, José Antonio Oteo Revuelta, Francisco Javier
Martínez Marcos, David Vinuesa García, Fernando Domínguez, Spanish Collaboration
on Endocarditis — Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España
(GAMES) (see Appendix) , Effect of the type of surgical indication on mortality in
patients with infective endocarditis who are rejected for surgical intervention. Ijca (2019),
https://doi.org/10.1016/j.ijcard.2019.01.014
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
© 2019. This manuscript version is made available under the CC-BY-NC-
ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
















Title: Effect of the type of surgical indication on mortality in patients with infective 
endocarditis who are rejected for surgical intervention 
 
 
Antonio Ramos-Martínez: aramos220@gmail.com. Unidad de Enfermedades Infecciosas. 
Servicio de Medicina Interna. Universitario Puerta de Hierro. Majadahonda. Madrid. 
 
Jorge Calderón-Parra: jorge050390@gmail.com. Servicio de Medicina Interna. Hospital 
Universitario Puerta de Hierro. Majadahonda. Madrid. 
 
José Mª Miró Meda: jmmiro@clinic.ub.es. Servicio de Enfermedades Infecciosas, Hospital 
Clinic-IDIBAPS. Universidad de Barcelona, Barcelona. 
 
Patricia Muñoz García: pmuñoz@micro.hggm.es. Servicio de Microbiología Clínica y 
Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid. Instituto 
de Investigación Sanitaria Gregorio Marañón. CIBER Enfermedades Respiratorias-CIBERES 
(CB06/06/0058). Facultad de Medicina, Universidad Complutense de Madrid. 
 
Hugo Rodríguez Abella: rhugorodriguez@yahoo.es. Servicio de Cirugía Cardiaca, Hospital 
General Universitario Gregorio Marañón, Madrid.  
 
Maricela Valerio Minero: mavami_valerio@yahoo.com.mx. Servicio de Microbiología Clínica y 
Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid. Instituto 
de Investigación Sanitaria Gregorio Marañón.  
 
Arístides de Alarcón González: aa2406ge@yahoo.es. Clinical Unit of Infectious Diseases, 
Microbiology and Preventive Medicine Infectious Diseases Research Group. Institute of 
Biomedicine of Seville (IBIS), University of Seville/CSIC/University Virgen del Rocío and Virgen 
Macarena. Seville. 
 
Rafael Luque Márquez: rluque@luque.jazztel.es. Clinical Unit of Infectious Diseases, 
Microbiology and Preventive Medicine Infectious Diseases Research Group. Institute of 
Biomedicine of Seville (IBIS), University of Seville/CSIC/University Virgen del Rocío and Virgen 
Macarena. Seville. 
 
Juan Ambrosioni: ambrosioni@clinic.ub.es. Servicio de Enfermedades Infecciosas, Hospital 
Clinic-IDIBAPS. Universidad de Barcelona, Barcelona. 
 
Mª Carmen Fariñas Álvarez: mcfarinas@humv.es. Infectious Diseases Unit. Hospital 
Universitario Marqués de Valdecilla. University of Cantabria, Santander.  
 
Miguel Ángel Goenaga Sánchez: goenagasanchez@gmail.com. Servicio de Enfermedades 
Infecciosas. Hospital Universitario Donosti. San Sebastián. 
 
José Antonio Oteo Revuelta: jaoteo@riojasalud.es. Servicio de Enfermedades Infecciosas, 
Hospital San Pedro. Centro de Investigación Biomédica de La Rioja (CIBIR) 
 
Francisco Javier Martínez Marcos: fcojmtz@telefonica.net. Unidad de Gestión Clínica de 
Enfermedades Infecciosas. Complejo Hospitalario Universitario de Huelva. Huelva.  
 
David Vinuesa García: vinudav@yahoo.es. Servicio de Medicina Interna y Enfermedades 

















Fernando Domínguez: fdominguezrodriguez@gmail.com. Servicio de Cardiología. Hospital 
Universitario Puerta de Hierro. Majadahonda. Madrid. 
 
On behalf of the Spanish Collaboration on Endocarditis – Grupo de Apoyo al Manejo de la 
Endocarditis Infecciosa en España (GAMES) (see Appendix) 
 
 
Author for correspondence: 
Antonio Ramos. Internal Medicine Department. Hospital Universitario Puerta de Hierro-
Majadahonda. C/ Maestro Rodrigo 2. Majadahonda. Madrid. 28222. Spain. Tel: +34 638 211 

















Aim: To evaluate the effect of the type of surgical indication on mortality in infective 
endocarditis (IE) patients who are rejected for surgery. 
 
Methods and results: From January 2008 to December 2016, 2714 patients with definite left-
sided IE were attended in the participating hospitals. One thousand six hundred and fifty-three 
patients (60.9%) presented surgical indications. Five hundred and thirty-eight patients (32.5%) 
presented surgical indications but received medical treatment alone. The indications for 
surgery in these patients were uncontrolled infection (366 patients, 68 %), heart failure (168 
patients, 31.3%) and prevention of embolism (148 patients, 27.6%). One hundred and thirty 
patients (24.2%) presented more than one indication. The mortality during hospital admission 
was 60% (323 patients). The in-hospital mortality of patients whose indication for surgery was 
heart failure, uncontrolled infection or risk of embolism was 75.6%, 61.4% and 54.7%, 
respectively (p<0.001). Surgical indications due to heart failure (OR: 3.24; CI 95%: 1.99-5.9) or 
uncontrolled infection (OR: 1.83; CI 95%: 1.04-3.18) were independently associated with a fatal 
outcome during hospital admission. Mortality during the first year was 75.4%. The mortality 
during the first year in patients whose indication for surgery was heart failure, uncontrolled 
infection or risk of embolism was 85.9%, 76.7% and 72.7%, respectively (p=0.016). Surgical 
indication due to heart failure (OR: 3.03; CI 95%: 1.53-5.98) were independently associated 
with fatal outcome during the first year. 
 
Conclusions. The type of surgical indication is associated with mortality in IE patients who are 
rejected for surgical intervention. 
 



















Infective endocarditis (IE) is a major health problem characterized by increasing incidence and 
high mortality [1]. Despite improvements in medical and surgical treatment, patient prognosis 
as a whole has not substantially changed which could be related to increases in patient age 
and hospital-acquired cases [2]. 
 
Although antibiotic treatment remains the mainstay of IE therapy, around half of the patients 
should undergo surgery, principally due to heart failure, uncontrolled infection or prevention 
of embolism [1,3,4]. Despite the benefits of surgical treatment being firmly established in 
cases with a clear indication, surgery is not performed in a high percentage and an unfavorable 
prognosis ensues [5]. 
 
It should be noted that the potential differences in mortality in patients with surgical 
indications but who are not subsequently submitted to the same have not been sufficiently 
studied. Although the great negative impact that congestive heart failure has on prognosis in 
IE patients who do not undergo surgery has been firmly established, this effect may not be so 
marked when the surgical indication is to prevent episodes of embolism [6]. According to 
certain studies, early cardiac surgery may reduce mortality in patients with large vegetations 
or cardio-embolic strokes [4]. On the other hand, a recent meta-analysis, which studied IE 
patients with complications due to ischemic stroke, showed no benefit in 1-year survival in 
patients who underwent early surgery [7]. In addition, certain current guidelines present some 
discrepancies with respect to surgical indications for preventing embolism [4]. Because of the 
above-mentioned findings, we proposed to analyze whether the type of surgical indication had 


















Patients and Methods 
 
From January 2008 to December 2016, 3,524 consecutive patients with definite or possible IE, 
according to the modified Duke criteria [8], were prospectively included in the “Spanish 
Collaboration on Endocarditis - Grupo de Apoyo al Manejo de la Endocarditis infecciosa en 
España (GAMES)” registry maintained by 27 Spanish hospitals. Right-sided IE cases and 
patients with cardiac device infection were excluded from this study unless there was 
concomitant left-side infection. Multidisciplinary teams completed standardized case report 
forms with IE episode and follow-up data that included clinical, microbiological and 
echocardiographic sections [9,10]. The study was approved by regional and local ethics 
committees and all patients gave their informed consent. Patients were included if they 
presented a surgical indication during the admission that endocarditis was diagnosed and the 
surgical team or the patient rejected surgery. 
 
Definitions 
Active IE was defined as endocarditis with at least one of the following: positive blood cultures, 
fever, leukocytosis, raised inflammation markers or current antibiotic treatment [10]. 
Microbiological diagnoses were determined by blood, valve culture and/or molecular 
techniques [10]. Transthoracic (TTE) and transesophageal echocardiography (TEE) were 
performed on patients with clinical or microbiological suspicion of IE according to European 
guidelines [4]. The same protocol was implemented for the diagnosis of valve dysfunction and 
intracardiac complications: abscess, vegetation, pseudoaneurysm and fistula [11]. We 
considered hospital-acquired IE as either IE manifesting >48 hours after admission to the 
hospital or IE acquired in association with a significant invasive procedure performed within 6 
months prior to diagnosis. The EuroScore and LogEuroScore were used to assess surgical risk 
[12]. All the necessary variables were collected to calculate the Charlson Comorbidity Index 
[13]. For better interpretation of the results, surgical indications were grouped according to 
the criteria and definitions of the European Guidelines (4). Consequently, the surgical 
indications were: 1) Heart failure manifested as Grade NYHA IV or III accompanied by valve 
regurgitation or severe stenosis or dehiscence of the prosthesis, 2) Prevention of embolism 
was considered when patients presented recurrent embolism and with a vegetation >10mm, 
vegetation >10mm together with regurgitation or severe aortic or mitral stenosis or had a 
vegetation >30mm, and 3) Uncontrolled infection was defined as the presence of 
















the same type of TTE or TEE, new heart block of any degree during the episode of endocarditis, 
persistent bacteremia (≥7 days despite an appropriate antibiotic regimen), fever persistent for 
more than 7 days, or aggressive bacillus: fungal, multiresistant organisms (e.g. prosthetic valve 
infection by methicillin-resistant S. aureus or vancomycin-resistant enterococci) as well as 
endocarditis caused by any type of non-HACEK gram-negative bacteria [4]. The timing of 
surgical intervention was defined as the median number of days between hospital admission 
and surgery. 
Hospital mortality was defined as death, regardless of cause, that occurred during the hospital 
admission in which cardiac surgery was indicated. The Cockcroft-Gault equation was used to 
calculate creatinine clearance [14]. Pre-episode renal insufficiency was defined as plasma 
creatinine over 1.4 mg/dl. New or worsening renal insufficiency during the IE episode was 
defined as exacerbation of baseline creatinine clearance or plasma creatinine by at least 25% 
or creatinine levels over 1.4 mg/dl when a previous analysis had been normal. Endocarditis 




Data from patients with IE were analyzed, which included clinical manifestations at IE 
presentation, the pathogens identified, therapy used as well as morbidity and mortality during 
hospitalization and during the first year after hospitalization. Indications for surgery were 
evaluated by a multidisciplinary team taking into account, not only the immediate surgical risk, 
but also the chances of long-term survival. Patients not initially considered for surgery that 
subsequently presented surgical indications were included in the "surgical group" in the same 
way as those who were candidates for surgery at hospital admission. No data was collected 
regarding the number of days that patients spent in the hospital prior to the surgical indication 
being established. The reasons for not undergoing surgery were assessed throughout the 
hospitalization period, in some cases, these reasons were apparent on admission, but in others 
they arose during the period of hospitalization, and even up to the moment that the surgery 
was programmed. Follow-up information was obtained via programmed medical reviews, by 
telephone or through written or electronic correspondence with each patient or their primary-
care physician. Patients were treated according to European endocarditis guidelines [4]. 
 
Statistical analysis 
Quantitative variables were reported as median and interquartile range (IQR), qualitative 
















using Student’s t-test, and categorical variables were compared using the chi-square test or 
Fisher’s exact test when appropriate. Adjusted odds ratios (ORs) were computed using logistic 
regression analysis. The variables related to patient prognoses could have been present at the 
time of hospital admittance or could have developed during the period of hospitalization. 
Stepwise logistic regression analysis was performed which mandatorily included surgical 
indication (heart failure, uncontrolled infection and prevention of embolism). For inclusion in 
the multivariate analysis, variables had to return a p value <0.1 and to also be considered 
clinically relevant. In order to avoid confounding variables, those that were very closely 
associated with death, such as septic shock, or consisted of a group of variables that were not 
strictly related to the pathogenesis or prognosis of endocarditis, were excluded from the 
analysis. It was considered appropriate to introduce one variable or factor for every 10 events 
in the multivariate analysis. Cox regression models for first-year survival according to surgical 
indication are shown in Figure 1 – 2. All statistical analyses were performed using SPSS 


















A total of 2,714 patients with definite left-sided infectious endocarditis were identified during 
the study period. One thousand six hundred and fifty three patients (60.9%) presented surgical 
indications. Among them, one thousand one hundred and fifteen (67.5%) underwent surgery 
during hospital admission. On the contrary, 538 patients (32.5%) presented surgical indication 
but received medical treatment alone. The indications for surgery in these patients were; 
uncontrolled infection (366 patients, 68 %), heart failure (168 patients 31.3%) and prevention 
of embolism (148 patients 27.6%, Table 1). One hundred and thirty patients (24.2%) presented 
more than one indication. The median time (and interquartile range) from hospital admission 
to surgery was 17 days (6 – 37 days). These values were 14 days (6 – 32 days) when the 
indication was heart failure, 23 days (9 – 44 days) in patients with uncontrolled infection, and 
11 days (4 – 29 days) in patients with a high risk of embolism (p<0.001 for the comparison 
between the three groups). Patients who did not undergo surgery more frequently presented 
advanced age, comorbidity, hospital acquisition, prosthetic endocarditis, staphylococcal 
infection, central nervous system (CNS) vascular events and septic shock (Table 1). The reasons 
for not undergoing surgery were; hemodynamic instability (112 patients, 20.8%), neurological 
complications (110 patients, 20.4%), notable surgical difficulty (67 patients, 12.4 %), other 
medical causes (113 patients, 21%), patient refusal (76 patients, 14.1%) and death before 
surgery (60 patients, 11.2%). 
 
In-hospital mortality was 60% (323 patients). The in-hospital mortality in patients whose 
indications for surgery were heart failure, uncontrolled infection or risk of embolism, was 
75.6%, 61.4% and 54.7%, respectively (p<0.001, Table 2). The cause of death during admission 
was heart failure in 178 patients (55.1%), infection in 98 patients (30.3%), CNS events in 46 
patients (14.2%) and other causes in 20 patients (6.7%). Nineteen patients (5.9%) presented 
more than one cause. In total, 359 patients died during the first year (75.4%). The first-year 
mortality in patients whose indication for surgery were heart failure, uncontrolled infection or 
risk of embolism, was 85.9%, 76.7, 72.7%, respectively (p=0.016). The clinical characteristics 
and the evolution of patients related to mortality one year after diagnosis are shown in Table 
3. A Cox regression model for one-year-survival according to surgical indication and treatment 
received is shown in Figures 1-5. Thirty-six patients died during the first year (after hospital 
discharge). Of these, 18 patients (50%) died due to heart failure, 3 patients (8.3%) due to CNS 
events and 2 patients (5.6%) due to infection. Seven patients (19.4%) presented other causes 

















Age >70 years, diabetes, neoplasia, previous renal insufficiency, age-adjusted Charlson index, 
hospital-acquired endocarditis, IE due to S. aureus, IE due to Streptococcus spp., renal function 
impairment and indication for surgery were included in the multivariate analysis (Table 2). 
Diabetes (OR: 1.88; CI 95%: 1.19-2.97), neoplasia (OR: 1.77; CI 95%: 1.02-3.07), renal function 
impairment (OR: 2.69; CI 95%: 1.77-4.07), IE due to S. aureus (OR: 1.61; CI 95%: 1.01-2.57), 
surgical indication due to heart failure (OR: 3.24; CI 95%: 1.99-5.9) and surgical indication due 
to uncontrolled infection (OR: 1.83; CI 95%: 1.04-3.18) were independently associated with a 
fatal outcome during hospital admission. 
 
Age >70 years, neoplasia, previous renal insufficiency, age-adjusted Charlson index, hospital-
acquired endocarditis, IE due to S. aureus, renal function impairment and surgery indication 
were included in the multivariate analysis (Table 3). Renal function impairment (OR: 2.35; CI 
95%: 1.43-3.87) and surgical indication due to heart failure (OR: 3.03; CI 95%: 1.53-5.98) were 





















This study analyzed the influence of the type of surgical indication on mortality in IE patients 
who did not undergo surgery despite such an intervention being indicated. The main result 
was that prevention of embolism, as the main reason for surgery, was less strongly associated 
with in-hospital mortality than heart failure or uncontrolled infection. 
 
Better knowledge concerning the indication and optimal timing of surgery, which is 
recommended in around 40%-60% of cases, has led to improved patient survival [5]. Despite 
this, the interaction between surgical indication, clinical severity, technical complexity of the 
surgery and the predictable prognosis is still a very complicated issue that can finally 
determine whether or not the patient receives surgical treatment [2,3 ,15,16]. 
 
It should be noted that surgery is not performed in 20%-40% of cases and is associated with 
notable adverse prognoses [5,15,16]. This may be related to underuse of scoring systems 
specifically designed for IE patients [19,17,18], lack of agreement between the attending 
team’s decision and current guidelines [16] or, more commonly, presumed high surgical risk as 
observed in other series [2,5,15]. To mitigate this problem, the surgical team should attempt 
to make decisions about treatment before IE complications prevent the patient from being 
considered suitable for surgical treatment [19]. 
 
In this study, mortality in patients in whom surgery was indicated but not performed was 60% 
during hospitalization and 75% during the first year, which is considerable but similar to other 
reported series [5,15]. The differences in mortality between patients who do or do not 
undergo surgery are attributable, not only to conservative treatment, but also to patient 
characteristics that may differ significantly between the two groups. As in other studies, 
advanced age, underlying comorbidities, immunosuppression, prosthetic valve endocarditis, 
CNS vascular events and septic shock were more commonly presented by patients who were 
denied surgical treatment [20]. One task that remains pending is to improve the selection of 
patients who present some risk factors for a poor prognosis but in whom surgery could still 
improve their vital prognosis [3,15]. 
 
In our series there was a marked difference in patients’ median age in relation to undergoing 
















years usually present noteworthy comorbidity and have a poor overall outcome, age alone 
should not preclude surgery [3,15,21,22]. Since surgical treatment is associated with a 
reasonably good outcome in these patients [3,15,22], suitable scoring systems should be used 
when considering comorbidities and other geriatric features for prognosis evaluation prior to 
performing cardiac surgery [15,23]. 
 
Although the identification of specific prognostic factors in patients with IE has been the 
subject of extensive study, none have focused on patients who are not considered suitable for 
surgical treatment [9,17,18]. The present study is, to our knowledge, the first to specifically 
analyze differences in mortality according to the indication for surgery in patients who are not 
submitted to surgery. 
 
Congestive heart failure, mainly due to valve insufficiency, is the most important predictor of 
in-hospital and long-term mortality [24]. In a propensity-matched study, patients with 
moderate-to-severe congestive heart failure showed the greatest reduction in mortality with 
surgery [14% vs 51%] [25]. Our study demonstrated that patients who did not undergo surgery 
when heart failure was the indication presented a significantly higher short- and long-term 
mortality. Hence, as far as possible, it is necessary to avoid delaying the recognition of heart 
failure so as to prevent the development of subsequent serious hemodynamic compromise 
[19]. 
 
Uncontrolled infection was the main surgical indication, which was a definite difference in 
comparison with other similar studies [3,5,16,25]. This result could be related to the high 
percentage of prosthetic-valve IE compared to other series [3,16]. One previous study 
observed that the most common indications for surgery in prosthetic-valve IE were, in 
descending order, uncontrolled infection [56%], embolization risk [30%] and heart failure 
[19%] [26]. In addition, in contrast to other studies, a high proportion of IE cases were due to 
S. aureus [29.8%] [5,15] that, in addition, underwent surgery less than expected despite the 
fact that intervention usually improves the prognosis [25, 45]. Satisfactory identification of 
patients with IE due to S. aureus who do not show a response to antibiotic treatment could 
help prevent the development of a septic state, which was the main reason for these patients 
not undergoing surgery [15,28]. 
 
Although systemic embolic events may arise at any moment during the clinical evolution of the 
















antibiotic treatment [29,30]. This means that surgical treatment to prevent embolism should 
be carried out early. However, a decisive study compared early surgery with conventional 
treatment in patients with IE and large vegetations and did not demonstrate any significant 
reduction in mortality [as an isolated variable] [31]. The lower mortality in cases not 
undergoing surgery when the indication was embolic risk may be related to the type and 
location of eventual vascular phenomena, such as silent CNS embolism, that would not trigger 
fatal complications [32]. 
Our study also illustrates that the "prevention of embolism" indication is not as relevant as 
heart failure [and uncontrolled infection] for predicting mortality in patients who are refused 
surgical treatment. This should not mean that the intervention should not be performed in 
patients who meet the criteria for embolism prevention included in clinical guidelines; on the 
contrary, it only suggests that the better short- and long-term prognosis, compared to other 
surgical indications of conservative treatment in these patients, should be taken into account 
when a decision not to intervene is under consideration by the surgical team and/or the 
patient. 
Some limitations of this study should be noted. Since current European guidelines criteria were 
followed, very different patients were grouped within the same category. Thus, with respect to 
uncontrolled infection, cases of persistent bacteremia were included in the same group as 
those with local progression of the infection [i.e. perivalvular abscess or pseudoaneurysm]. 
Similarly, the severity of patients with a vegetation greater than 10 mm and severe valvular 
insufficiency could mainly be due to the later development of heart failure than to the risk of 
embolism [the category in which they were finally included]. Moreover, the high proportion of 
patients with more than one surgical indication limits the power of the study to determine the 
effects of this variable on patient prognosis. Another limitation is that data concerning the 
number of patients who developed surgical indications during hospitalization, which were not 
present on admission, was not collected. In addition, most of the institutions participating in 
the GAMES registry are tertiary university hospitals that receive a substantial number of 
patients referred from other centers [most of which do not have facilities for cardiac surgery], 
which could represent a selection bias. Similarly, a possible cluster effect cannot be ruled out. 
However, we do not believe that the heterogeneity between centers is sufficient to have a 

















In summary, our study demonstrates that the type of surgical indication should be taken into 
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Table 1. Characteristics of IE patients and surgical indication related to treatment during 
admission 
 
 Medical treatment 
(n=538) 
Medical and surgical 
treatment (n=1115) 
P 
Age (years) 74 (63 - 79) 65 (54 - 73) <0.001 
Male gender 301 (55.9) 743 (66.6) <0.001 
Hospital-acquired 201 (37.3) 277 (24.8) <0.001 
Comorbidity    
Diabetes mellitus 170 (31.5) 271 (24.3) 0.002 
Renal insufficiency 1 185 (34.4) 229 (20.5) <0.001 
Implantable cardiac device 77 (14.3) 68 (6.1) <0.001 
Age-adjusted Charlson Comorbidity Index 
(points) 6 (4 - 7) 4 (2 - 5) <0.001 
Microbiology    
Coagulase-negative staphylococci  160 (29.7) 161 (14.4) <0.001 
S. aureus 107 (19.9) 104 (9.3) <0.001 
Streptococcus spp 89 (16.5) 319 (28.6) <0.001 
Enterococcus spp 81 (15.1) 150 (13.5) 0.379 
Affected valve    
Native 332 (61.7) 723 (64.8) 0.214 
Prosthetic 230 (42.8) 398 (35.7) 0.006 
Aortic 310 (57.6) 762 (68.3) <0.001 
Mitral 314 (58.4) 520 (46.6) <0.001 
Clinical complications    
Septic shock 127 (23.6) 135 (12.1) <0.001 
Persistent bacteremia 104 (19.3) 119 (10.6) <0.001 
CNS vascular events 166 (30.8) 223 (20.0) <0.001 
Non-neurologic embolisms 121 (22.4) 232 (20.8) 0.472 
Heart failure 336 (62.4) 664 (59.5) 0.281 
Renal function impairment 238 (44.6) 470 (42.3) 0.393 
Intracardiac complications    
Perivalvular abscess 140 (26.0) 336 (30.1) 0.094 
Pseudoaneurysm 41 (7.6) 119 (10.6) 0.060 
Intracardiac fistula 25 (4.6) 56 (5.0) 0.833 
Surgery indication 132 (55.0) 40 (42.6) 0.041 
Heart failure 168 (31.2) 466 (41.8) <0.001 
Uncontrolled infection 366 (68.0) 602 (54.0) 0.153 
Prevention of embolism 148 (27.5) 345 (30.9) <0.001 
In-hospital mortality 366 (68.0) 290 (26.0) <0.001 
One-year mortality 2 359 (75.4) 333 (33.7) <0.001 
 
CNS: central nervous system. Quantitative variables are reported with median and 
interquartile range. 1 Renal insufficiency was defined as plasma creatinine over 1.4 mg/dl. No 


































Table 2. Clinical characteristics of IE patients who did not undergo surgery related to in-hospital 
mortality. 
 
 Survivors (n=215) Non-survivors (n=323) OR (CI 95%) P 
Age (years) 72 (63 - 79) 75 (64 - 80)  0.199 
Male gender 127 (59.0) 174 (53.8)  0.270 
Hospital-acquired 70 (32.5) 131 (40.5)  0.073 
Comorbidity     
Diabetes mellitus 53 (24.7) 117 (36.6) 1.88 (1.19-2.97) 0.006 
Renal insufficiency 1 60 (27.9) 125 (38.7)  0.010 
Chronic liver disease 32 (15.3) 58 (18.4)  0.357 
Neoplasia 32 (15.0) 67 (20.9) 1.77 (1.02-3.07) 0.041 
Immunosuppressive therapy 15 (7.0) 27 (8.4)  0.540 
Implantable cardiac device 25 (11.6) 52 (16.1)  0.143 
Age-adjusted Charlson Comorbidity 
Index (points) 5 (4 - 7) 6 (4 - 8) 
 
0.003 
Microbiology     
Coagulase-negative staphylococci  43 (20.0) 64 (19.8)  0.958 
S. aureus 48 (22.3) 112 (34.7) 1.61 (1.01-2.57) 0.046 
Streptococcus spp 48 (22.3) 41  (12.7)  0.003 
Enterococcus spp 38 (17.7) 43 (13.3)  0.166 
Affected valve     
Native 130 (60.5) 202 (62.5)  0.628 
Prosthetic 96 (44.7) 134 (41.5)  0.467 
Aortic 117 (54.4) 193 (59.8)  0.220 
    Mitral 130 (60.5) 184 (57.0)  0.420 
Clinical complications     
Septic shock 22 (10.2) 105 (32.5)  <0.01 
Persistent bacteremia 35 (16.5) 69 (22.0)  0.118 
CNS vascular events 62 (28.8) 104 (33.0)  0.308 
Non-neurologic embolisms 46 (21.5) 75 (24.0)  0.496 
Heart failure 73 (43.9) 243 (76.2)  <0.01 
Renal function impairment 60 (28.0) 178 (55.6) 2.69 (1.77-4.07) <0.001 
Intracardiac complications     
Perivalvular abscess 55 (25.6) 85 (26.3)  0.953 
Pseudoaneurysm 18 (8.4) 23 (7.1)  0.726 
Intracardiac fistula 12 (5.6) 13 (4.0)  0.683 
Surgery indication 2     
Heart failure 41 (19.1) 127 (39.3) 3.24 (1.99-5.9) <0.001 
Uncontrolled infection 141 (65.6) 225 (69.7) 1.83 (1.04-3.18) 0.037 
Prevention of embolism 67 (31.2) 81 (25.1) 1.34 (0,78.2,31) 0.122 
 
CNS: central nervous system. Quantitative variables are reported with median and 
interquartile range. 1 Renal insufficiency was defined as plasma creatinine over 1.4 mg/dl. 2 

















Table 3. Clinical characteristics patients presenting with IE refused for surgery according to one-year 
mortality 
 Survivors (n=117) Non-survivors (n=359) OR (CI 95%) P 
Age (years) 70 (59 - 78) 75 (64 - 80)  0.011 
Male gender 74 (63.2) 197 (54.8)  0.138 
Hospital-acquired 33 (28.2) 143 (39.8)  0.031 
Comorbidity     
Diabetes mellitus 27 (23.1) 128 (36.0)  0.010 
Renal insufficiency 1 25 (21.4) 141 (39.3)  <0.001 
Chronic liver disease 13 (11.1) 67 (18.6)  0.079 
Neoplasia 14 (11.9) 77 (21.4)  0.033 
Immunosuppressive therapy 11 (9.4) 28 (7.8)  0.454 
Implantable cardiac device 11 (9.4) 56 (15.6)  0.092 
Age-adjusted Charlson Comorbidity 
Index (points) 5 (3 - 6) 6 (4 - 8) 
 
<0.001 
EuroScore 25 (10 - 48) 54 (29 - 71)  <0.001 
Microbiology     
Coagulase-negative staphylococci  21 (17.9) 73 (20.3)  0.573 
S. aureus  26 (22.2) 122 (34.0)  0.017 
Streptococcus spp 22 (18.8) 49 (13.6)  0.174 
Enterococcus spp 23 (19.7) 46 (12.8)  0.093 
Affected valve     
Native 75 (64.1) 226 (63.0)  0.823 
Prosthetic 51 (43.6) 147 (40.9)  0.615 
Aortic 63 (53.8) 212 (59.1)  0.322 
    Mitral 78 (66.7) 202 (56.3)  0.047 
Vegetation size (mm) 10 (7 – 15) 12 (7 – 17)  0.614 
Clinical complications     
Septic shock 14 (12.0) 106 (29.5)  <0.001 
Persistent bacteremia 20 (17.4) 77 (22.1)  0.285 
CNS vascular events 34 (29.0) 114 (31.7)  0.665 
Non-neurologic embolisms 26 (22.2) 84 (23.3)  0.892 
Heart failure 49 (42.2) 262 (73.8)  <0.001 
Renal function impairment 32 (27.4) 192 (53.9) 2.35 (1.43-3.87) <0.001 
Intracardiac complications     
Perivalvular abscess 26 (22.2) 93 (25.9)  0.511 
Pseudoaneurysm 8 (6.8) 28 (7.8)  0.570 
Intracardiac fistula 6 (5.1) 14 (3.9)  0.616 
Surgery indication 3        
Heart failure  22 (18.8) 134 (37.3) 3.03 (1.53-5.98) <0.001 
Uncontrolled infection 75 (64.1) 247 (68.8) 1.9 (0.96-3.77) 0.345 
Prevention of embolism 36 (30.8) 96 (26.7) 1.77 (0.9-3.46) 0.398 
CNS: central nervous system. Quantitative variables are reported with median and 
interquartile range. 1 In-hospital mortality. 2 Renal insufficiency was defined as plasma 
creatinine over 1.4 mg/dl..  3 One hundred twenty patients (22.4%) presented than one 





















 Clinical guidelines allow to group patients according to the surgical indication 
 Many IE patients are not operated on despite presenting a clear surgical indication 
 The type surgical indication may influence the mortality of these patients 
 Prevention of embolism, as surgical indication, is associated with lower mortality  
 Conversely, CHF is associated with higher short- and long-term mortality  
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